Virtual Screening Directly Identifies New Fragment-Sized Inhibitors of Carboxylesterase Notum with Nanomolar Activity.
Animals
Binding Sites
Carboxylic Ester Hydrolases
/ antagonists & inhibitors
Crystallography, X-Ray
Enzyme Inhibitors
/ chemical synthesis
Esterases
/ antagonists & inhibitors
High-Throughput Screening Assays
Male
Mice
Mice, Inbred C57BL
Models, Molecular
Molecular Docking Simulation
Protein Binding
Structure-Activity Relationship
Wnt Signaling Pathway
/ drug effects
beta Catenin
/ drug effects
Journal
Journal of medicinal chemistry
ISSN: 1520-4804
Titre abrégé: J Med Chem
Pays: United States
ID NLM: 9716531
Informations de publication
Date de publication:
13 01 2022
13 01 2022
Historique:
pubmed:
24
12
2021
medline:
8
2
2022
entrez:
23
12
2021
Statut:
ppublish
Résumé
Notum is a negative regulator of Wnt signaling acting through the hydrolysis of a palmitoleoylate ester, which is required for Wnt activity. Inhibitors of Notum could be of use in diseases where dysfunctional Notum activity is an underlying cause. A docking-based virtual screen (VS) of a large commercial library was used to shortlist 952 compounds for experimental validation as inhibitors of Notum. The VS was successful with 31 compounds having an IC
Identifiants
pubmed: 34939789
doi: 10.1021/acs.jmedchem.1c01735
doi:
Substances chimiques
Enzyme Inhibitors
0
beta Catenin
0
Esterases
EC 3.1.-
Carboxylic Ester Hydrolases
EC 3.1.1.-
Notum protein, mouse
EC 3.1.1.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
562-578Subventions
Organisme : Cancer Research UK
ID : C375/A17721
Pays : United Kingdom